Baby aspirin can prevent stroke, but whether it will help you depends almost entirely on one question: have you already had a stroke or mini-stroke, or are you trying to prevent your first one? For people who have already experienced a stroke or transient ischemic attack (TIA), low-dose aspirin reduces the risk of another ischemic stroke by roughly 60% in the critical first six weeks. For people with no history of stroke or heart disease, the benefit is far less clear, and major guidelines now recommend against starting it for most adults over 60.
How Aspirin Prevents Blood Clots
Most strokes are ischemic, meaning a blood clot blocks an artery supplying the brain. Aspirin works by permanently disabling an enzyme in platelets, the small blood cells responsible for clotting. Specifically, it shuts down the production of a chemical called thromboxane A2, which normally signals platelets to clump together. Because platelets can’t repair themselves, a single dose of aspirin keeps each affected platelet from clotting for its entire 7 to 10 day lifespan. This is why even a small daily dose has a cumulative, powerful effect on clot formation.
“Baby aspirin” refers to 81 mg in the United States and 75 mg in the United Kingdom. Both are considered low-dose. Some European trials use 100 mg. All three doses are well within the range shown to block platelet clumping effectively.
Strong Evidence for a Second Stroke
If you’ve already had an ischemic stroke or TIA, the case for aspirin is strong. A time-course analysis published in The Lancet found that aspirin reduced the six-week risk of another ischemic stroke by about 60%. The benefit was even more dramatic for the most dangerous outcomes: disabling or fatal recurrent strokes dropped by roughly 70% overall, and by up to 90% in patients whose initial event was a TIA or minor stroke.
Over the longer term, aspirin provides a more modest 13% reduction in recurrent stroke risk. The biggest payoff comes in those first days and weeks after an event, when the risk of a second stroke is highest. This is why emergency departments typically give aspirin immediately after confirming an ischemic (not hemorrhagic) stroke.
Weak Case for Preventing a First Stroke
For people who have never had a stroke or heart attack, the math changes. The U.S. Preventive Services Task Force issued updated guidance drawing a sharp line:
- Adults 40 to 59 with an estimated 10-year cardiovascular risk of 10% or higher may benefit, but the decision should be individualized. The net benefit is small.
- Adults 60 and older should not start aspirin for primary prevention. The Task Force concluded with moderate certainty that there is no net benefit for this group, because the rising risk of bleeding offsets any clot-prevention gains.
The reason for this shift is straightforward. As you age, your blood vessels become more fragile, and the same antiplatelet effect that prevents clots also makes bleeding harder to stop. In a large trial of healthy adults over 65, published in the New England Journal of Medicine, those taking daily low-dose aspirin experienced major hemorrhage at a rate of 8.6 events per 1,000 person-years compared to 6.2 in the placebo group, a 38% increase. That includes hemorrhagic stroke, bleeding inside the skull, and serious gastrointestinal bleeds requiring hospitalization.
Bleeding Risks to Weigh
Gastrointestinal bleeding is the most common serious side effect. Western studies report GI bleed rates of 0.7% to 1.3% per year for people on aspirin alone. That may sound low, but these bleeds accumulate over time. In one 10-year observational study of patients on antiplatelet therapy, the cumulative bleeding rate reached 11% by the end of the decade.
The risk climbs further if you take aspirin alongside other blood-thinning medications, have a history of stomach ulcers, drink alcohol regularly, or use anti-inflammatory painkillers like ibuprofen. Hemorrhagic stroke, while rarer than GI bleeding, is the most feared complication because aspirin can worsen bleeding in the brain, turning what might have been a minor event into a life-threatening one.
Alternatives to Aspirin
Aspirin is not the only antiplatelet option. Clopidogrel (sold as Plavix) works through a different mechanism, blocking a separate receptor on platelets. A systematic review and meta-analysis comparing the two after a recent ischemic stroke found that clopidogrel reduced recurrent ischemic stroke risk by 28% more than aspirin alone. It also carried a 43% lower risk of bleeding events. For patients who can’t tolerate aspirin or who experience a stroke while already taking it, clopidogrel is a common alternative.
In the first few weeks after a TIA or minor stroke, doctors sometimes prescribe both aspirin and clopidogrel together for a short period, then transition to one medication. This dual approach carries higher bleeding risk and is not intended for long-term use.
Not Everyone Responds to Aspirin
A surprising number of people don’t get the expected antiplatelet benefit from aspirin. A meta-analysis of over 10,700 cardiovascular patients found that about 25% showed laboratory-defined aspirin resistance, meaning their platelets continued to clump despite regular aspirin use. The rate was slightly higher in women (27%) than in men (24%). This doesn’t mean aspirin does nothing for these individuals, but it may explain why some people have strokes despite being on aspirin therapy. There is no routine clinical test for aspirin resistance, so most people and their doctors won’t know unless a cardiovascular event occurs.
Why You Shouldn’t Stop Aspirin Abruptly
If you’ve been taking aspirin for secondary prevention, stopping suddenly is risky. A large Swedish cohort study found that patients who discontinued aspirin after at least a year of treatment experienced a 37% increase in cardiovascular events. That translates to one additional heart attack, stroke, or cardiovascular death for every 74 patients who stopped each year. In the secondary prevention setting specifically, the increase was 46%.
This isn’t just the loss of protection. There appears to be a genuine rebound effect: platelet activity surges after aspirin withdrawal, temporarily making clots more likely than if you’d never taken aspirin at all. The spike in events happens quickly, within days to weeks of stopping. If you need to discontinue aspirin for surgery or another reason, the timing and transition should be planned with your doctor rather than done on your own.
Who Benefits Most
The clearest benefit belongs to people who have already had an ischemic stroke or TIA, especially in the high-risk window immediately after the event. For this group, low-dose aspirin is a cornerstone of secondary prevention, dramatically reducing the chance of a second, potentially more severe stroke.
For people with no prior stroke or heart disease, the picture is murkier. Younger adults with significant cardiovascular risk factors (high blood pressure, diabetes, smoking, high cholesterol) may see a modest benefit that outweighs the bleeding risk. For healthy adults over 60, current evidence says the bleeding risk cancels out any stroke prevention benefit, and starting aspirin is not recommended. If you’re already taking it and wondering whether to continue, that conversation depends on your personal risk profile, not a blanket rule.